
Sotatercept Phase 3 Program Design and Rationale: A Novel Treatment for Pulmonary Arterial Hypertension
This study was presented by Dr. Ioana R Preston, Tufts Medical Center, Boston, MA; on th Sunday November 14 at the 2021 American Heart Association